Self-Experimentation in the Time of COVID-19

Scientists are taking their own vaccines, an ethically murky practice that has a long and sometimes celebrated history in medicine.

Written byAmanda Heidt
| 6 min read
vaccine, Covid-19, coronavirus, SARS-CoV-2, pandemic, self experimentation, polio, poliovirus, yellow fever, Jonas Salk, Joseph Goldberger, George Church

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

ABOVE: © ISTOCK.COM, MARY HERRON

Long before there were rumors of COVID parties (decline your invitation), there were actual “filth parties,” and the guest list was exclusive. Joseph Goldberger, an infectious disease expert in the US Public Health Service, was tasked in 1914 with determining the cause of pellagra, a systemic disease known for its four Ds—dermatitis, diarrhea, dementia, and death.

Many physicians at the time believed pellagra stemmed from an unknown germ, but Goldberger felt strongly, correctly, that it was the result of a nutritional deficiency. To prove it, he and his wife Mary held small gatherings during which they and a few brave volunteers injected themselves with the blood of pellagra victims and ate the feces and urine of patients in pill form, what Mary called “the most nauseating diabolical concoctions,” according to a 2014 book detailing Joseph’s work. Goldberger repeated this spectacle multiple times in cities through ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • amanda heidt

    Amanda first began dabbling in scicom as a master’s student studying marine science at Moss Landing Marine Labs, where she edited the student blog and interned at a local NPR station. She enjoyed that process of demystifying science so much that after receiving her degree in 2019, she went straight into a second master’s program in science communication at the University of California, Santa Cruz. Formerly an intern at The Scientist, Amanda joined the team as a staff reporter and editor in 2021 and oversaw the publication’s internship program, assigned and edited the Foundations, Scientist to Watch, and Short Lit columns, and contributed original reporting across the publication. Amanda’s stories often focus on issues of equity and representation in academia, and she brings this same commitment to DEI to the Science Writers Association of the Rocky Mountains and to the board of the National Association of Science Writers, which she has served on since 2022. She is currently based in the outdoor playground that is Moab, Utah. Read more of her work at www.amandaheidt.com.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery